Jagsonpal Pharmaceuticals Limited — Dividend/Bonus, 06-05-2026: Buyback

Jagsonpal Pharma announces a share buyback! The company plans to repurchase up to 1.6 million shares (~₹40 Cr) at ₹250 per share through a tender offer. The buyback window opens on May 8, 2026, and closes on May 14, 2026. Promoters will not participate in the offer. Post-buyback, promoter stake is projected to rise from 67.71% to 69.36%, while public shareholding will adjust from 32.29% to 30.64%. This move aims to enhance shareholder value and improve Return on Equity by returning surplus cash.